Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Clinical Pharmacokinetics|February 18, 2016
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia SyndromeStephanie E Reuter, Jennifer H Martin
Clinical Pharmacokinetics|July 19, 2012
Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspectsStephanie E Reuter, Allan M Evans
Pharmacology Research & Perspectives|June 28, 2024
Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patientsSherilyn Wong, Philip R Selby, Stephanie E Reuter
Australian Occupational Therapy Journal|March 23, 2011
Reliability and validity of indices of hand-grip strength and enduranceStephanie E Reuter, Nicola Massy-Westropp, Allan M Evans
Nephrology (Carlton, Vic.)|January 18, 2008
L-carnitine supplementation in the dialysis population: are Australian patients missing out?Stephanie E Reuter, Randall J Faull, Allan M Evans
Clinical Pharmacokinetics|April 18, 2016
How 'Optimal' are Optimal Sampling Times for Tyrosine Kinase Inhibitors in Cancer? Practical ConsiderationsMichael B Ward, Stephanie E Reuter, Jennifer H Martin
CPT: Pharmacometrics & Systems Pharmacology|November 15, 2018
Reducing Palivizumab Dose Requirements Through Rational Dose Regimen DesignStephanie E Reuter, Allan M Evans, Michael B Ward
Cannabis and Cannabinoid Research|April 21, 2022
Population Pharmacokinetics of Oral-Based Administration of Cannabidiol in Healthy Adults: Implications for Drug DevelopmentHayley B Schultz, Adele Hosseini, Andrew J McLachlan, et al.
Annals of Clinical Biochemistry|September 11, 2008
Determination of the reference range of endogenous plasma carnitines in healthy adultsStephanie E Reuter, Allan M Evans, Donald H Chace, et al.
Pageof 6